Patents by Inventor Veronique Bailly

Veronique Bailly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TIM-1 Antibodies And Uses Thereof
    Publication number: 20150110792
    Abstract: Antibodies and antibody fragments that bind to human TIM-1 on the BED face of the protein are disclosed. Also disclosed are methods of using the antibodies and antibody fragments to inhibit or reduce TIM-1 binding to phosphatidylserine, inhibit or reduce TIM-1 binding to dendritic cells, and treat or prevent immunological disorders such as inflammatory and autoimmune conditions.
    Type: Application
    Filed: November 16, 2012
    Publication date: April 23, 2015
    Inventors: Veronique Bailly, Ellen Garber, Paul D. Rennert, Nicholas Joseph Lennemann, Wendy Jean Maury, Sven Henrik Moller-Tank
  • Light targeting molecules and uses thereof
    Patent number: 8734795
    Abstract: LIGHT-targeting molecules (e.g., LIGHT fusion molecules), anti-HER2 antibody molecules, compositions, e.g., pharmaceutical compositions thereof, are disclosed. Methods of using these molecules to treat, prevent and/or diagnose hyperproliferative, e.g., neoplastic, diseases or conditions, including, but not limited to, cancer and metastasis are also provided.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: May 27, 2014
    Assignee: Biogen Idec MA Inc.
    Inventors: Xinzhong Wang, Veronique Bailly, Alexey Lugovskoy, Graham K. Farrington, Christilyn Graff, Scott Glaser
  • KIM-1 ANTIBODIES FOR TREATMENT OF TH2-MEDIATED CONDITIONS
    Publication number: 20130089539
    Abstract: Compositions and methods for treating Th2- and Th1-mediated disease are provided.
    Type: Application
    Filed: April 4, 2012
    Publication date: April 11, 2013
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Paul Rennert, Patricia McCoon, Veronique Bailly, Alexey Lugovskoy
  • KIM-1 antibodies for treatment of TH2-mediated conditions
    Patent number: 8206705
    Abstract: Compositions and methods for treating Th2- and ThI-mediated disease are provided.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: June 26, 2012
    Assignee: Biogen Idec MA Inc.
    Inventors: Paul Rennert, Patricia McCoon, Veronique Bailly, Alexey Lugovskoy
  • Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents
    Patent number: 7947271
    Abstract: Receptor coupling agents, including multivalent constructs comprising anti-TNF receptor binding moieties, for treating cancer and inhibiting tumor volume in a subject are disclosed.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: May 24, 2011
    Assignee: Biogen Idec MA Inc.
    Inventors: Jeffrey L. Browning, Veronique Bailly, Ellen Garber
  • RECEPTOR COUPLING AGENTS AND THERAPEUTIC USES THEREOF
    Publication number: 20100266542
    Abstract: Receptor coupling agents, including multivalent constructs comprising anti-TNF receptor binding moieties, for treating cancer and inhibiting tumor volume in a subject are disclosed.
    Type: Application
    Filed: January 26, 2010
    Publication date: October 21, 2010
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Jeffrey L. BROWNING, Veronique BAILLY, Ellen GARBER
  • Receptor coupling agents and compositions thereof
    Patent number: 7799902
    Abstract: Receptor coupling agents, including multivalent constructs comprising anti-TNF receptor binding moieties, for treating cancer and inhibiting tumor volume in a subject are disclosed.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: September 21, 2010
    Assignee: Biogen Idec MA Inc.
    Inventors: Jeffrey L. Browning, Veronique Bailly, Ellen Garber
  • KIM-1 ANTIBODIES FOR TREATMENT OF TH2-MEDIATED CONDITIONS
    Publication number: 20100150905
    Abstract: Compositions and methods for treating Th2- and ThI-mediated disease are provided.
    Type: Application
    Filed: March 2, 2006
    Publication date: June 17, 2010
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Paul Rennert, Patricia McCoon, Veronique Bailly, Alexey Lugovskoy
  • LIGHT TARGETING MOLECULES AND USES THEREOF
    Publication number: 20100119511
    Abstract: LIGHT-targeting molecules (e.g., LIGHT fusion molecules), anti-HER2 antibody molecules, compositions, e.g., pharmaceutical compositions thereof, are disclosed. Methods of using these molecules to treat, prevent and/or diagnose hyperproliferative, e.g., neoplastic, diseases or conditions, including, but not limited to, cancer and metastasis are also provided.
    Type: Application
    Filed: October 30, 2009
    Publication date: May 13, 2010
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Xinzhong Wang, Veronique Bailly, Alexey Lugovskoy, Graham K. Farrington, Christilyn Graff
  • Molecules and methods for inhibiting shedding of KIM-1
    Patent number: 7696321
    Abstract: Disclosed are antibodies that inhibit proteolytic release of a soluble KIM-1 polypeptide from KIM-1 expressing cells. Also disclosed are methods of using the antibodies to inhibit shedding of the KIM-1 polypeptide.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: April 13, 2010
    Assignees: Biogen Idec MA Inc., The General Hospital Corporation
    Inventors: Veronique Bailly, Joseph V. Bonventre
  • RON antibodies and uses thereof
    Publication number: 20090226442
    Abstract: The invention relates to antibodies which bind to RON (receptor d'origine nantais, MST1R) and uses thereof, in particular in the diagnosis and treatment of cancer. Specific antibodies which inhibit RON-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific antibodies which block the ability of the ligand, MSP to bind to RON, as well as fragments, variants and derivatives of such antibodies. The invention also includes polynucleotides encoding the above antibodies or fragments, variants or derivatives thereof, as well as vectors and host cells comprising such polynucleotides. The invention further includes methods of diagnosing and treating cancer using antibodies of the invention.
    Type: Application
    Filed: January 22, 2009
    Publication date: September 10, 2009
    Inventors: Heather Huet, Veronique Bailly, Ellen Garber, Christilyn Graff, Steven Miklasz
  • Molecules and Methods for Inhibiting Shedding of KIM-1
    Publication number: 20080124336
    Abstract: Disclosed are antibodies that inhibit proteolytic release of a soluble KIM-1 polypeptide from KIM-1 expressing cells. Also disclosed are methods of using the antibodies to inhibit shedding of the KIM-1 polypeptide.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 29, 2008
    Applicants: BIOGEN IDEC MA INC., THE GENERAL HOSPITAL CORPORATION
    Inventors: Veronique Bailly, Joseph Bonventre
  • Molecules and methods for inhibiting shedding of KIM-1
    Patent number: 7300652
    Abstract: Disclosed are antibodies that inhibit proteolytic release of a soluble KIM-1 polypeptide from KIM-1 expressing cells. Also disclosed are methods of using the antibodies to inhibit shedding of the KIM-1 polypeptide.
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: November 27, 2007
    Assignees: Biogen Idec MA Inc., The General Hospital Corporation
    Inventors: Veronique Bailly, Joseph Bonventre
  • Receptor coupling agents and therapeutic uses thereof
    Publication number: 20070154476
    Abstract: Receptor coupling agents, including multivalent constructs comprising anti-TNF receptor binding moieties, for treating cancer and inhibiting tumor volume in a subject are disclosed.
    Type: Application
    Filed: September 21, 2006
    Publication date: July 5, 2007
    Inventors: Jeffrey Browning, Veronique Bailly, Ellen Garber
  • Molecules and methods for inhibiting shedding of KIM-1
    Publication number: 20060153836
    Abstract: Disclosed are antibodies that inhibit proteolytic release of a soluble KIM-1 polypeptide from KIM-1 expressing cells. Also disclosed are methods of using the antibodies to inhibit shedding of the KIM-1 polypeptide.
    Type: Application
    Filed: February 7, 2006
    Publication date: July 13, 2006
    Inventors: Veronique Bailly, Joseph Bonventre
  • Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
    Publication number: 20060104971
    Abstract: Multivalent antibody constructs that are specific for the human lymphotoxin beta receptor, as well as their use in treating cancer and inhibiting tumor volume in a subject are disclosed.
    Type: Application
    Filed: June 17, 2005
    Publication date: May 18, 2006
    Applicant: Biogen Idec MA Inc.
    Inventors: Ellen Garber, Veronique Bailly, Jeffrey Browning
  • Molecules and methods for inhibiting shedding of KIM-1
    Patent number: 7041290
    Abstract: Disclosed are antibodies that inhibit proteolytic release of a soluble KIM-1 polypeptide from KIM-1 expressing cells. Also disclosed are methods of using the antibodies to inhibit shedding of the KIM-1 polypeptide.
    Type: Grant
    Filed: November 20, 2003
    Date of Patent: May 9, 2006
    Assignees: Biogen Idec MA Inc., The General Hospital Corporation
    Inventors: Veronique Bailly, Joseph Bonventre
  • Molecules and methods for inhibiting shedding of KIM-1
    Publication number: 20050112117
    Abstract: Disclosed are antibodies that inhibit proteolytic release of a soluble KIM-1 polypeptide from KIM-1 expressing cells. Also disclosed are methods of using the antibodies to inhibit shedding of the KIM-1 polypeptide.
    Type: Application
    Filed: November 20, 2003
    Publication date: May 26, 2005
    Inventors: Veronique Bailly, Joseph Bonventre